Gotthardová I - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

KCNQ1 gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors.

Gotthardová I, Javorský M, Klimčáková L, Kvapil M, Schroner Z, Kozárová M, Malachovská Z, Ürgeová A, Židzik J, Tkáč I. Gotthardová I, et al. Diabetes Res Clin Pract. 2017 Aug;130:142-147. doi: 10.1016/j.diabres.2017.05.018. Epub 2017 May 19. Diabetes Res Clin Pract. 2017. PMID: 28624668

Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancers.

Tkáč I, Gotthardová I. Tkáč I, et al. Among authors: gotthardova i. Pharmacogenomics. 2016 May;17(7):795-804. doi: 10.2217/pgs-2016-0011. Epub 2016 May 11. Pharmacogenomics. 2016. PMID: 27166975 Review.

A missense variant in GLP1R gene is associated with the glycaemic response to treatment with gliptins.

Javorský M, Gotthardová I, Klimčáková L, Kvapil M, Židzik J, Schroner Z, Doubravová P, Gala I, Dravecká I, Tkáč I. Javorský M, et al. Among authors: gotthardova i. Diabetes Obes Metab. 2016 Sep;18(9):941-4. doi: 10.1111/dom.12682. Epub 2016 Jun 7. Diabetes Obes Metab. 2016. PMID: 27160388

Genetic variants associated with glycemic response to treatment with dipeptidylpeptidase 4 inhibitors.

Űrgeová A, Javorský M, Klimčáková L, Židzik J, Šalagovič J, Hubáček JA, Doubravová P, Gotthardová I, Kvapil M, Pelikánová T, Tkáč I, Yaluri AS. Űrgeová A, et al. Among authors: gotthardova i. Pharmacogenomics. 2020 Apr;21(5):317-323. doi: 10.2217/pgs-2019-0147. Epub 2020 Apr 20. Pharmacogenomics. 2020. PMID: 32308134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters